No Result
View All Result
  • Login
Wednesday, February 4, 2026
FeeOnlyNews.com
  • Home
  • Business
  • Financial Planning
  • Personal Finance
  • Investing
  • Money
  • Economy
  • Markets
  • Stocks
  • Trading
  • Home
  • Business
  • Financial Planning
  • Personal Finance
  • Investing
  • Money
  • Economy
  • Markets
  • Stocks
  • Trading
No Result
View All Result
FeeOnlyNews.com
No Result
View All Result
Home Money

Scary or Smart? AI Could Soon Decide Your Health Insurance

by FeeOnlyNews.com
4 months ago
in Money
Reading Time: 5 mins read
A A
0
Scary or Smart? AI Could Soon Decide Your Health Insurance
Share on FacebookShare on TwitterShare on LInkedIn


Image Source: 123rf.com

Could the same artificial intelligence that helps recommend movies or drive cars soon decide which medical treatments you get (or don’t)? The healthcare world is already testing that boundary. In Oklahoma, Medicare is rolling out a pilot to use an AI health insurance model to make prior authorization decisions. While proponents promise efficiency and cost control, critics warn of hidden dangers: opaque logic, biased denials, and diminished patient agency. Understanding where this is heading matters to every insured American.

Here are seven alarming (or at least challenging) realities that emerge when AI health insurance becomes more than theory.

1. Automation may speed denials, even when they’re wrong

One of the most obvious risks is how fast AI systems can reject claims or prior authorizations. Recent studies and reports show that algorithmic denials can outpace human decision-making by orders of magnitude. But speed doesn’t guarantee fairness, especially when many decisions are opaque. In some cases, AI systems output a denial without clear justification or the possibility of a meaningful explanation. That means patients and physicians are left to guess how to appeal or challenge the decision.

2. The “black box” problem erodes accountability

AI models often use complex, opaque logic that even their developers may struggle to explain. In insurance settings, that opacity becomes dangerous: if a claim is denied, how can you know whether it was fair? Without transparency, patients have little recourse to challenge misjudgments or bias. Even regulators may struggle to audit algorithmic decisions if they can’t access or parse the logic. This problem intensifies when health and access to care are on the line.

3. Bias in data can translate to discriminatory outcomes

AI learns from historical data, and if that data reflects systemic bias, the AI can replicate it. Certain demographic groups may be underrepresented in training sets, or past inequities may skew decisions. The result? Some patients could be unfairly flagged as “high risk” or systematically denied coverage. These skewed outcomes may amplify existing disparities in healthcare access and outcomes. The stakes are high when AI health insurance decisions disproportionately disadvantage vulnerable populations.

4. Physicians raise alarms about patient harm

Doctors are sounding warnings about what AI-driven insurance decisions could mean for patient care. A recent survey from the American Medical Association reported that 61% of physicians worry that insurers’ use of AI increases denial rates. They argue that algorithmic denials risk delaying necessary treatments or blocking access altogether. When care is held up by opaque logic, patients may suffer worsened outcomes.

“Using AI-enabled tools to automatically deny more and more needed care is not the reform of prior authorization that physicians and patients are calling for,” AMA President Bruce A. Scott, M.D., said.

He continued, “Emerging evidence shows that insurers use automated decision-making systems to create systematic batch denials with little or no human review, placing barriers between patients and necessary medical care. Medical decisions must be made by physicians and their patients without interference from unregulated and unsupervised AI technology.”

5. Real-world pilots already underway

This isn’t science fiction. In states including Oklahoma, Arizona, New Jersey, Texas, and Washington, a new pilot called the “Wasteful and Inappropriate Service Reduction” (WISeR) program will let AI systems assist (or even decide) Medicare prior authorization for certain treatments starting in 2026. The pilot targets procedures such as spine surgeries and certain injections. Critics worry the incentives built into the system may be biased toward denials. With real patients at stake, the experiment will test whether AI health insurance can live up to its promise, or credibility will erode.

6. Legal and regulatory safeguards remain catching up

Insurers already use AI for underwriting, claims processing, fraud detection, and more. But using AI to make coverage decisions raises deeper legal and ethical questions. Regulators are beginning to respond: some states propose rules that AI systems must not override clinician judgment or discriminate based on protected attributes. Yet many jurisdictions still lack robust oversight or accountability mechanisms. As AI health insurance expands, legislation and regulation must evolve fast to protect patient rights and safety.

7. The fight for transparency and appeal is already forming

In the face of algorithmic denials, countermeasures are emerging. A new startup, Counterforce Health, uses AI to help patients craft appeal letters against denials. In addition, insurers face increasing lawsuits and regulatory scrutiny over mass denials.

The Guardian spoke with a mother, Deirdre O’Reilly, who spoke about her child receiving life-saving emergency care that wound up being denied insurance coverage, thanks to AI. Her son, who has a life-threatening food allergy, was attending college out of state. He started having an allergic reaction and, like every other time this has happened, he headed into the nearest emergency room. “My son didn’t have a choice – he was going to die if he didn’t go to the nearest emergency room,” O’Reilly said.

However, she was shocked when she received a $5,000 bill in the mail. Insurance wasn’t going to cover any of it. Unfortunately, O’Reilly, who works in healthcare, has said that she’s seen this happen in real time. In some heartbreaking cases, families with premature infants are denied oxygen equipment.

“It’s gotten out of control. It’s changed a tremendous amount in the 20 years I’ve been a physician,” O’Reilly said. “I can’t believe that people have to go through this just to get healthcare covered – things that are basic needs.”

The pushback reflects growing public concern over unaccountable systems making life-or-death decisions. As AI health insurance becomes more common, patient advocacy and legal push are likely to intensify.

A Crossroads for AI Health Insurance

We’re at a pivotal moment. The shift toward AI health insurance is neither inherently evil nor infallibly good. It depends on how we build, regulate, and monitor it. If safeguards, transparency, and human oversight are absent, the balance could tip toward cost-driven denial rather than patient welfare. For citizens, this means staying informed, pushing for fair appeals, and demanding clarity. The question isn’t whether AI will play a role, but whether we’ll let it decide our care without consent or comprehension.

Do you trust an algorithm to decide whether your medical treatment is covered? What conditions should be in place to ensure fairness and accountability if AI health insurance becomes standard? Share your thoughts in the comments below.

What to Read Next

AI Call Centers at SSA—Will They Make Benefits Access Easier or Impossible?
How Is Artificial Intelligence Changing Retirement Planning—and Who’s Losing?
Health Insurance After a Layoff: A Plain‑English Decision Tree
Medicare Part B Hikes No One Wants to Talk About
Enrollment Mistakes That Can Wipe Out Your Medicare Coverage Completely



Source link

Tags: decideHealthInsurancescarySmart
ShareTweetShare
Previous Post

The U.S. economy is running even hotter than previously thought, and GDP growth could reach 4% in Q3

Next Post

Medicare’s AI Could Deny the Pain Treatment Your Doctor Prescribes

Related Posts

8 Prescription Refill Rules That Are Costing Retirees More in 2026

8 Prescription Refill Rules That Are Costing Retirees More in 2026

by FeeOnlyNews.com
February 4, 2026
0

For millions of retirees, 2026 was promised to be the year of relief. The Inflation Reduction Act finally implemented the...

9 Reasons More Than Half of Americans Are Terrified of Their Emergency Savings

9 Reasons More Than Half of Americans Are Terrified of Their Emergency Savings

by FeeOnlyNews.com
February 3, 2026
0

Emergency funds sound comforting in theory, but they can feel scary in real life. Many people look at their emergency...

6 Shared Expense Arrangements That Rarely Stay Fair

6 Shared Expense Arrangements That Rarely Stay Fair

by FeeOnlyNews.com
February 3, 2026
0

Splitting costs with someone else sounds simple until real life starts shifting under your feet. One person gets a raise,...

5 Financial Favors That Are Hard to Undo

5 Financial Favors That Are Hard to Undo

by FeeOnlyNews.com
February 3, 2026
0

Saying yes to help someone out can feel like the right thing, especially when it’s “just this once,” and they...

As a CPA, I Thought I Knew Social Security — Until I Retired. Here Are 5 Costly Blunders Even the Experts Make.

As a CPA, I Thought I Knew Social Security — Until I Retired. Here Are 5 Costly Blunders Even the Experts Make.

by FeeOnlyNews.com
February 3, 2026
0

I’m a CPA and personal finance writer with more than 30 years of experience, which includes writing dozens of articles...

6 Estate Planning Shortcuts That Backfire During Health Crises

6 Estate Planning Shortcuts That Backfire During Health Crises

by FeeOnlyNews.com
February 3, 2026
0

Estate planning is often sold as a way to handle death, but its most critical function is actually handling life—specifically,...

Next Post
Medicare’s AI Could Deny the Pain Treatment Your Doctor Prescribes

Medicare’s AI Could Deny the Pain Treatment Your Doctor Prescribes

Bombay Stock Exchange rejects company listing for crypto investments

Bombay Stock Exchange rejects company listing for crypto investments

  • Trending
  • Comments
  • Latest
Self-driving startup Waabi raises up to  billion, partners with Uber to deploy 25,000 robotaxis

Self-driving startup Waabi raises up to $1 billion, partners with Uber to deploy 25,000 robotaxis

January 28, 2026
Student Beans made him a millionaire, a heart condition made this millennial founder rethink life

Student Beans made him a millionaire, a heart condition made this millennial founder rethink life

December 11, 2025
Sellers Are Accepting Even Less

Sellers Are Accepting Even Less

January 23, 2026
Will CRCL Stock Recover by the End of Jan 2026?

Will CRCL Stock Recover by the End of Jan 2026?

January 10, 2026
Episode 242. “Our couples therapist couldn’t fix this. Please help.”

Episode 242. “Our couples therapist couldn’t fix this. Please help.”

January 6, 2026
US SEC Issues Key Crypto Custody Guidelines For Broker-Dealers

US SEC Issues Key Crypto Custody Guidelines For Broker-Dealers

December 19, 2025
Ethereum’s L2 Scaling Story Gets a Rewrite From Vitalik Buterin

Ethereum’s L2 Scaling Story Gets a Rewrite From Vitalik Buterin

0
Fund buys control of car parts co M PInes for NIS 500m

Fund buys control of car parts co M PInes for NIS 500m

0
8 Prescription Refill Rules That Are Costing Retirees More in 2026

8 Prescription Refill Rules That Are Costing Retirees More in 2026

0
The Home Depot (HD): Baumarkt-Gigant lässt den Gesamtmarkt stehen!

The Home Depot (HD): Baumarkt-Gigant lässt den Gesamtmarkt stehen!

0
We just got reasons to love these 2 portfolio stocks even more

We just got reasons to love these 2 portfolio stocks even more

0
Johnson & Johnson’s Getting Back to Double-Digit Growth. Has the Stock Become a Bargain Buy?

Johnson & Johnson’s Getting Back to Double-Digit Growth. Has the Stock Become a Bargain Buy?

0
8 Prescription Refill Rules That Are Costing Retirees More in 2026

8 Prescription Refill Rules That Are Costing Retirees More in 2026

February 4, 2026
Ethereum’s L2 Scaling Story Gets a Rewrite From Vitalik Buterin

Ethereum’s L2 Scaling Story Gets a Rewrite From Vitalik Buterin

February 4, 2026
Johnson & Johnson’s Getting Back to Double-Digit Growth. Has the Stock Become a Bargain Buy?

Johnson & Johnson’s Getting Back to Double-Digit Growth. Has the Stock Become a Bargain Buy?

February 4, 2026
Fund buys control of car parts co M PInes for NIS 500m

Fund buys control of car parts co M PInes for NIS 500m

February 4, 2026
The Home Depot (HD): Baumarkt-Gigant lässt den Gesamtmarkt stehen!

The Home Depot (HD): Baumarkt-Gigant lässt den Gesamtmarkt stehen!

February 4, 2026
Top Lessons From a Record Trading Month

Top Lessons From a Record Trading Month

February 4, 2026
FeeOnlyNews.com

Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.

CATEGORIES

  • Business
  • Cryptocurrency
  • Economy
  • Financial Planning
  • Investing
  • Market Analysis
  • Markets
  • Money
  • Personal Finance
  • Startups
  • Stock Market
  • Trading

LATEST UPDATES

  • 8 Prescription Refill Rules That Are Costing Retirees More in 2026
  • Ethereum’s L2 Scaling Story Gets a Rewrite From Vitalik Buterin
  • Johnson & Johnson’s Getting Back to Double-Digit Growth. Has the Stock Become a Bargain Buy?
  • Our Great Privacy Policy
  • Terms of Use, Legal Notices & Disclaimers
  • About Us
  • Contact Us

Copyright © 2022-2024 All Rights Reserved
See articles for original source and related links to external sites.

Welcome Back!

Sign In with Facebook
Sign In with Google
Sign In with Linked In
OR

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Business
  • Financial Planning
  • Personal Finance
  • Investing
  • Money
  • Economy
  • Markets
  • Stocks
  • Trading

Copyright © 2022-2024 All Rights Reserved
See articles for original source and related links to external sites.